With the immunology CRO

We can tell your molecule’s story


Our mission is to unlock discoveries and develop solutions for biopharmaceutical companies seeking to overcome substantial scientific challenges by providing data of outstanding quality


Meet us in person at upcoming events

We’re pleased to announce that in 2024 we’ll be exhibiting at the following prestigious conferences: 

  • Immuno-Oncology Summit Europe in London: 23-25 April – Booth #13
  • Immuno 2024 - in London: 25 April – Our CSO speaking on Day 1 at 2.10pm, Track 1
  • Festival of Biologics in San Diego: 15-17 April – Booth #824
  • Immuno-Oncology Summit US in Philadelphia: 7-9 August – Booth #3
  • Society for Immunotherapy for Cancer (SITC) in Texas: 6-10 November – Booth TBC



Our new transformational IndEx-2 system has launched

A powerful, inducible cell system that allows selection of the safest and most efficacious targeted therapies. IndEx-2 is an in vitro cell-based platform that provides inducible expression of any target antigen of interest (TAOI).

  • Safety: Gain information on the potential of “on target, off tumour effects” via precise control of TAOI expression to model physiological and pathological expression levels
  • Efficacy: Determine the antigen density activation threshold of targeted immunotherapies, including immune cell engagers, ADCs and engineered immune cell therapies

IndEx-2 is an effective tool that can be used to enhance a pre-clinical data package with information that offers a more comprehensive understanding of a targeted drug mechanism of action and functional profile. 



Read our latest news and browse our scientific resource articles